Ketan K. Badani, MD, a renowned expert in robotic surgery for kidney and prostate cancer, has joined the Mount Sinai Health System as Vice Chairman of Urology and Robotic Operations, and Director of the Comprehensive Kidney Cancer Program.
Having completed more than 4,000 robotic kidney and prostate surgeries during his career, Dr. Badani, Professor of Urology at Icahn School of Medicine at Mount Sinai, is considered one of the most experienced specialists in the field. He has authored more than 150 peer-reviewed publications and co-wrote the book Robotic Prostatectomy for Prostate Cancer–Is It for You?
In the past, kidney cancer treatment involved removing the entire affected kidney, but today, robotics have allowed partial nephrectomy—the partial removal of the kidney—to be increasingly used in treating this type of cancer. Dr. Badani pioneered FAST (first assistant sparing technique), which decreases both the time it takes to complete the robotic surgery and the length of time the affected kidney is without blood flow during the procedure. An enthusiastic teacher, Dr. Badani has trained physicians throughout the world on these robotic techniques. Additionally, he has published research on his techniques for the recovery of sexual and urinary function after prostate cancer surgery, which have resulted in greater precision and shorter recovery times associated with robotic procedures in more complex patients.
“Our program is treating the most challenging kidney tumors, and we are safely performing robotic partial nephrectomy with the lowest overall complication rates,” says Dr. Badani. “I am really excited to be working with Mount Sinai’s team of oncologists, urologists, nephrologists, and radiologists, who are committed to offering the highest level of care to our patients.”
Prior to his appointments at Mount Sinai, Dr. Badani served as the Director of Robotic Surgery and Director of Research for Prostate and Kidney Cancer Outcomes at Columbia University Medical Center.